Who owns CONTINEUM THERAPEUTICS INC?
- Ticker: CTNM
- CUSIP Number: 21217b100
Tip: Access positions for across all investors
Analyze quarterly positions in Contineum Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Contineum Therapeutics stock
Who bought or sold CONTINEUM THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Suvretta Capital Management | 2.8M | $33M | 65% | Dec 2025 |
|
| RA Capital Management | 2.2M | $25M | 3% | Dec 2025 |
|
| Johnson & Johnson | 2.0M | $23M | 0% | Dec 2025 |
|
| Franklin Resources | 1.9M | $22M | 14% | Dec 2025 |
|
| Balyasny Asset Management | 1.8M | $21M | 94% | Dec 2025 |
|
| Perceptive Advisors | 1.5M | $17M | 105% | Dec 2025 |
|
| Baker Bros. Advisors | 1.4M | $16M | 1729% | Dec 2025 |
|
| Vanguard Group | 1.3M | $15M | 32% | Dec 2025 |
|
| Millennium Management | 831k | $9.5M | 25% | Dec 2025 |
|
| Commodore Capital | 816k | $9.3M | 100% | Dec 2025 |
|
| FMR | 815k | $9.3M | 0% | Dec 2025 |
|
| Sectoral Asset Management | 801k | $9.2M | 0% | Dec 2025 |
|
| Dr. Jeffrey R. Jay, M.D. | 800k | $9.1M | 100% | Dec 2025 |
|
| Point72 Asset Management | 759k | $8.7M | 107% | Dec 2025 |
|
| Hillhouse Capital Advisors | 669k | $7.7M | 0% | Dec 2025 |
|
| Red Tree Management | 638k | $8.3M | 0% | Mar 2026 |
|
| Versant Venture Management | 543k | $6.2M | 0% | Dec 2025 |
|
| BlackRock | 536k | $6.1M | 66% | Dec 2025 |
|
| Boxer Capital Management | 494k | $5.6M | 100% | Dec 2025 |
|
| Silverarc Capital Management | 308k | $3.5M | 85% | Dec 2025 |
|
| Ikarian Capital | 283k | $3.2M | 100% | Dec 2025 |
|
| ADAR1 Capital Management | 279k | $3.2M | 258% | Dec 2025 |
|
| Susquehanna International | 276k | $3.2M | 35% | Dec 2025 |
|
| Geode Capital Management | 214k | $2.4M | 1% | Dec 2025 |
|
| Ameriprise Financial | 210k | $2.4M | 100% | Dec 2025 |
|
| UBS Group | 199k | $2.3M | 191% | Dec 2025 |
|
| Marshall Wace | 181k | $2.1M | -7% | Dec 2025 |
|
| Sphera Funds Management | 174k | $2.0M | 100% | Dec 2025 |
|
| Casdin Capital | 148k | $1.7M | 0% | Dec 2025 |
|
| Eversept Partners | 138k | $1.6M | 2% | Dec 2025 |
|
| Monashee Investment Management | 137k | $1.6M | 100% | Dec 2025 |
|
| Charles Schwab Investment Management | 110k | $1.3M | 0% | Dec 2025 |
|
| Goldman Sachs Group | 106k | $1.2M | 250% | Dec 2025 |
|
| 683 Capital Management | 91k | $1.0M | 100% | Dec 2025 |
|
| State Street Corporation | 84k | $965k | 35% | Dec 2025 |
|
| Boothbay Fund Management | 73k | $829k | 100% | Dec 2025 |
|
| Samsara BioCapital | 72k | $826k | -87% | Dec 2025 |
|
| Acadian Asset Management | 65k | $735k | 144% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 64k | $734k | 29095% | Dec 2025 |
|
| Barclays | 60k | $680k | 819% | Dec 2025 |
|
| Trexquant Investment | 59k | $675k | 101% | Dec 2025 |
|
| Renaissance Technologies | 57k | $653k | 39% | Dec 2025 |
|
| Northern Trust | 54k | $616k | 10% | Dec 2025 |
|
| ExodusPoint Capital Management | 51k | $583k | 100% | Dec 2025 |
|
| Strategies Wealth Advisors | 50k | $572k | 0% | Dec 2025 |
|
| Bridgeway Capital Management | 49k | $563k | 19% | Dec 2025 |
|
| Qube Research & Technologies | 43k | $492k | 100% | Dec 2025 |
|
| Jane Street | 42k | $479k | 100% | Dec 2025 |
|
| Two Sigma Investments | 38k | $433k | 0% | Dec 2025 |
|
| OMERS Administration Corporation | 35k | $399k | 100% | Dec 2025 |
|
| Hudson Bay Capital Management | 26k | $297k | 100% | Dec 2025 |
|
| Quadrature Capital | 23k | $267k | 100% | Dec 2025 |
|
| Schonfeld Strategic Advisors | 23k | $259k | 23% | Dec 2025 |
|
| Rbf Capital | 20k | $229k | -50% | Dec 2025 |
|
| American Century Companies | 20k | $223k | 100% | Dec 2025 |
|
| Brevan Howard Capital Management | 19k | $222k | 100% | Dec 2025 |
|
| Graham Capital Management | 17k | $195k | 100% | Dec 2025 |
|
| Occudo Quantitative Strategies | 15k | $172k | 100% | Dec 2025 |
|
| Persistent Asset Partners | 14k | $158k | 100% | Dec 2025 |
|
| Cannon Global Investment Management | 13k | $170k | 100% | Mar 2026 |
|
| China Universal Asset Management | 3.8k | $43k | 100% | Dec 2025 |
|
| Federation des caisses Desjardins du Quebec | 2.6k | $29k | 0% | Dec 2025 |
|
| CWM | 1.2k | $13k | -6% | Dec 2025 |
|
| Mirae Asset Global Investments | 1.1k | $13k | 100% | Dec 2025 |
|
| Gf Fund Management | 513.00 | $6.7k | 13% | Mar 2026 |
|
| Banque Transatlantique SA | 220.00 | $2.5k | 100% | Dec 2025 |
|
| Tower Research Capital | 124.00 | $1.4k | -93% | Dec 2025 |
|
| Optiver Holding B.V. | 104.00 | $1.2k | 0% | Dec 2025 |
|
| Group One Trading | 103.00 | $1.2k | -79% | Dec 2025 |
|
Who sold out of Contineum Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Squarepoint Ops | Sep 2025 | 13k | $154k |
| Bailard | Sep 2025 | 12k | $145k |
| Mariner Wealth Advisors | Sep 2025 | 10k | $122k |
| Wells Fargo & Company | Sep 2025 | 5.4k | $63k |
| Simplex Trading | Sep 2025 | 895.00 | $10k |
| Fortitude Family Office | Dec 2025 | 445.00 | $5.1k |